openPR Logo
Press release

What Is Driving Global Circulating Tumor DNA (CtDNA) Methylation Market Growth in 2025: The Role of Rise In Cancer Prevalence Driving The Growth Of The Market Due To Increasing Demand For Early Detection And Personalized Treatment

10-08-2025 04:08 PM CET | Health & Medicine

Press release from: The Business Research Company

Circulating Tumor DNA CtDNA Methylation

Circulating Tumor DNA CtDNA Methylation

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Circulating Tumor DNA (CtDNA) Methylation Market Size Growth Forecast: What to Expect by 2025?
In recent times, there has been a swift surge in the market size for circulating tumor DNA (CtDNA) methylation. This market, valued at $1.30 billion in 2024, is projected to grow to $1.48 billion in 2025, with a compound annual growth rate (CAGR) of 13.6%. The historic growth can be traced back to factors such as the escalating number of ctDNA methylation clinical trials, a surge in the adoption of precision medicine approaches, growing utility of biomarkers for prognosis, an increased number of published research endorsing the application of ctDNA methylation, and the rise in the implementation of high-end lab automation.

How Will the Circulating Tumor DNA (CtDNA) Methylation Market Size Evolve and Grow by 2029?
We are likely to witness a substantial surge in the size of the circulating tumor DNA (CtDNA) methylation market in the chronology to come, with prognostications pointing to a growth to $2.43 billion by the year 2029, representing a compound annual growth rate (CAGR) of 13.2%. The prediction of growth over the forecast period is attributable to various factors - the surge in point-of-care ctDNA testing solutions, the escalating adoption of telemedicine which promotes remote diagnostics, heightened global consciousness about epigenetic biomarkers, a rise in cross-industry collaborations and an upswing in partnerships between research entities and diagnostic firms. The upcoming trends that are expected to shape the market over the forecast period involve the inclusion of bioinformatics in methylation profiling, advancements in monitoring treatment response, innovations in mass screening programs, the integration of automated specimen processing systems, and novel progress in providing targeted therapy guidance.

View the full report here:
https://www.thebusinessresearchcompany.com/report/circulating-tumor-dna-ctdna-methylation-global-market-report

What Drivers Are Propelling the Growth of Circulating Tumor DNA (CtDNA) Methylation Market Forward?
The escalating incidence of cancer is projected to fuel the expansion of the circulating tumor DNA (ctDNA) methylation market in the future. The rise in cancer cases is attributed to an aging population and lifestyle-related risk factors such as unhealthy diet, smoking, and lack of physical activity that enhance the chance of genetic alterations and tumor formation. ctDNA methylation tests assist in early, non-invasive cancer detection, provide accurate disease progression monitoring, and facilitate personalized treatment decision-making, leading to timely and precise clinical interventions. As an example, the National Cancer Institute, a US government agency, estimated that in May 2024, cancer survivors' count in the United States would rise from 18.1 million in 2022 to 26 million by 2040. Hence, the escalating incidence of cancer is stimulating the growth of the ctDNA methylation market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=28167&type=smp

Which Emerging Trends Are Transforming the Circulating Tumor DNA (CtDNA) Methylation Market in 2025?
Companies leading the circulating tumor DNA (ctDNA) methylation market are prioritizing the creation of multi-cancer early detection (MCED) blood tests. These tests allow for the early, non-invasive detection of various cancer types by analyzing specific ctDNA methylation patterns. This patient outcome-enhancing method identifies distinctive methylation signatures, enabling swift intervention and assisting with accurate clinical decision making. For example, in September 2025, Exact Sciences Corporation, a US molecular diagnostics company, brought Cancerguard to the market. This MCED blood test uses ctDNA methylation analysis to detect unique methylation signatures across over 50 types of cancer. It provides non-invasive, extremely sensitive detection, giving clinicians valuable information and aiding in continuous monitoring and treatment decisions. This innovation is a significant move towards improving survival rates by facilitating early intervention in cancer treatment with a focus on precision.

What Are the Key Segments in the Circulating Tumor DNA (CtDNA) Methylation Market?
The circulating tumor dna (CtDNA) methylation market covered in this report is segmented as

1) By Product Type: Reagents And Kits, Instrumentations, Software And Bioinformatics Solutions, Services
2) By Technology: Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Microarray, Other Technologies
3) By Sample Type: Blood Samples, Urine Samples, Saliva Samples, Tissue Samples, Other Samples
4) By Application: Oncology, Cardiovascular Diseases, Neurological Disorders, Infectious Diseases, Other Applications
5) By End-User: Hospitals And Clinics, Research Laboratories, Diagnostic Laboratories, Pharmaceutical And Biotechnology Companies, Academic Institutions

Subsegments:
1) By Reagents And Kits: Cell Free DNA Extraction Kits, Bisulfite Conversion Kits, Methylation Detection Kits, Library Preparation Kits, Targeted Enrichment Kits
2) By Instrumentations: Sequencers, Real Time Polymerase Chain Reaction Systems, Digital Polymerase Chain Reaction Systems, Microarray Scanners, Droplet Digital Polymerase Chain Reaction Systems
3) By Software And Bioinformatics Solutions: Data Analysis Software, Methylation Pattern Interpretation Software, Genomic Visualization Tools, Pipeline Automation Software, Clinical Reporting Software
4) By Services: Sample Processing Services, Sequencing Services, Bioinformatics Analysis Services, Clinical Trial Support Services, Consultation And Training Services

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=28167&type=smp

Who Are the Key Players Shaping the Circulating Tumor DNA (CtDNA) Methylation Market's Competitive Landscape?
Major companies operating in the circulating tumor dna (ctdna) methylation market are Thermo Fisher Scientific Inc., Agilent Technologies Inc., Illumina Inc., Sysmex Corporation, Bio-Rad Laboratories Inc., Exact Sciences Corporation, Qiagen N.V., Natera Inc., BGI Group, Guardant Health Inc., Invitae Corporation, Grail Inc., Genetron Holdings Limited, Buing Rock Biotech Limited, Zymo Research Corp, Agena Bioscience Inc., Phalanx Biotech Group Inc., Epigenomics Ag, EpigenDx Inc., Singlera Genomics Inc., Sampled.

What Geographic Markets Are Powering Growth in the Circulating Tumor DNA (CtDNA) Methylation Market?
North America was the largest region in the circulating tumor DNA (CtDNA) methylation market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in circulating tumor DNA (ctDNA) methylation report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=28167

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release What Is Driving Global Circulating Tumor DNA (CtDNA) Methylation Market Growth in 2025: The Role of Rise In Cancer Prevalence Driving The Growth Of The Market Due To Increasing Demand For Early Detection And Personalized Treatment here

News-ID: 4214341 • Views:

More Releases from The Business Research Company

Future of the Global Cloud-Based Health Management Systems Market: Trends, Innovations, and Key Forecasts Through 2034
Future of the Global Cloud-Based Health Management Systems Market: Trends, Innov …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Cloud-Based Health Management Systems Market Size Growth Forecast: What to Expect by 2025? In recent years, the market size for cloud-based health management systems has seen significant growth. The market is projected to increase from a value of $21.98 billion in 2024 to a worth of $25.34 billion in
Clinical Wearable Virtual Reality Market Poised to Hit $3.49 Billion by 2029 with Accelerating Growth Trends
Clinical Wearable Virtual Reality Market Poised to Hit $3.49 Billion by 2029 wit …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Clinical Wearable Virtual Reality Market Size Growth Forecast: What to Expect by 2025? The market size of clinical wearable virtual reality has seen a sharp increase in recent years. This is set to grow from $1.46 billion in 2024 to $1.74 billion in 2025, representing a compound annual growth
Emerging Trends to Drive Cellular Therapy Tracking Market Growth at 12.9% CAGR Through 2029
Emerging Trends to Drive Cellular Therapy Tracking Market Growth at 12.9% CAGR T …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Cellular Therapy Tracking Market Size Growth Forecast: What to Expect by 2025? The market size for cellular therapy tracking has experienced swift expansion in recent times. The projected growth is from $2.56 billion in 2024 to $2.90 billion in 2025, which corresponds to a compound annual growth rate (CAGR)
Key Drivers Reshaping the Cardiogenomics Testing Panels Market: Rising Prevalence Of Inherited Cardiovascular Diseases Driving The Market Growth Due To Advances In Genetic Testing And Early Diagnosis Industry Transformation
Key Drivers Reshaping the Cardiogenomics Testing Panels Market: Rising Prevalenc …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Cardiogenomics Testing Panels Market Size Growth Forecast: What to Expect by 2025? Recent years have seen a swift expansion in the cardiogenomics testing panels market size. Projected to ascend from $1.38 billion in 2024 to $1.55 billion by 2025, the market is expected to experience a compound annual growth

All 5 Releases


More Releases for DNA

High-Quality Plasmid DNA Fuels Growth in Global DNA Plasmid Manufacturing Market
🌍 Market Overview The DNA Plasmid Manufacturing Market is experiencing robust growth as advancements in cell & gene therapy, DNA vaccines, and genetic engineering continue to expand globally. Plasmid DNA plays a critical role as a raw material in the development of advanced therapies, fueling demand across biopharmaceutical research and production. Key factors driving the market include: Increasing adoption of gene and cell therapies Rising prevalence of chronic and rare genetic disorders Expansion of DNA-based
DNA Synthesis Market Increasing Demand for Synthetic Genes and DNA Sequences
As demonstrated by Precision Business Insights (PBI), the latest report, the global DNA synthesis market was valued at USD 3,702.0 million in 2023 and is expected to reach USD 10,289.5 million by 2029, growing at a CAGR of 18.6% during the forecast period 2024-2030. The key drivers for the growth of the global DNA synthesis market include increasing demand for synthetic genes and DNA sequences, growing applications in the agriculture
Wealth DNA Code Review Legit Price? (Wealth Manifestation DNA Code Audio Frequen …
Wealth DNA Code Wealth DNA Code is a digital program with seven minutes of soundtracks that manifest and listen to daily to activate the "Wealth DNA," which is part of your DNA to help you attract wealth by making money a part of your mentality and making your dreams to come true. https://bit.ly/Visit-The-Official-Website-Here-To-Order-Wealth-DNA-Code Making money, creating assets as well as increasing wealth are the primary objectives that every human being has to
DNA Paternity Testing Market Size [2022-2029] -DNA Diagnostics Center, EasyDNA, …
A recent market research report added to repository of MR Accuracy Reports is an in-depth analysis of global DNA Paternity Testing. On the basis of historic growth analysis and current scenario of DNA Paternity Testing place, the report intends to offer actionable insights on global market growth projections. Authenticated data presented in report is based on findings of extensive primary and secondary research. Insights drawn from data serve as excellent
DNA Paternity Testing Market Trends 2020 | Growth by Top Companies: DNA Diagnost …
The report begins with the overview of the DNA Paternity Testing Market and offers throughout development. It presents a comprehensive analysis of all the regional and major player segments that gives closer insights upon present market conditions and future market opportunities along with drivers, trending segments, consumer behaviour, pricing factors and market performance and estimation. The forecast market information, SWOT analysis, DNA Paternity Testing market scenario, and feasibility study are
DNA Paternity Testing Market Rapidly Growing in Healthcare, Competitor Analysis …
The exclusive research report on the Global DNA Paternity Testing Market 2020 examines the market in detail along with focusing on significant market dynamics for the key players operating in the market. Global DNA Paternity Testing Industry research report offers granulated yet in-depth analysis of revenue share, market segments, revenue estimates and various regions across the globe. Overview of Global DNA Paternity Testing Market: This report studies the Global DNA Paternity Testing